Influence of Cannabinoid Receptor 1 Genetic Variants on the Subjective Effects of Smoked Cannabis.
Thomas MurphyJustin MathesonRobert E MannBruna BrandsChristine M WickensArun K TiwariClement C ZaiJames KennedyBernard Le FollPublished in: International journal of molecular sciences (2021)
As many jurisdictions consider relaxing cannabis legislation and usage is increasing in North America and other parts of the world, there is a need to explore the possible genetic differences underlying the subjective effects of cannabis. This pilot study investigated specific genetic variations within the cannabinoid receptor 1 (CNR1) gene for association with the subjective effects of smoked cannabis. Data were obtained from a double-blinded, placebo-controlled clinical trial studying the impact of cannabis intoxication on driving performance. Participants randomized to the active cannabis group who consented to secondary genetic analysis (n = 52) were genotyped at the CNR1 rs1049353 and rs2023239 polymorphic areas. Maximum value and area under the curve (AUC) analyses were performed on subjective measures data. Analysis of subjective effects by genotype uncovered a global trend towards greater subjective effects for rs1049353 T-allele- and rs2023239 C-allele-carrying subjects. However, significant differences attributed to allelic identity were only documented for a subset of subjective effects. Our findings suggest that rs1049353 and rs2023239 minor allele carriers experience augmented subjective effects during acute cannabis intoxication.
Keyphrases
- sleep quality
- clinical trial
- placebo controlled
- double blind
- genome wide
- depressive symptoms
- randomized controlled trial
- squamous cell carcinoma
- gene expression
- open label
- phase ii
- radiation therapy
- intensive care unit
- phase iii
- physical activity
- binding protein
- liver failure
- acute respiratory distress syndrome
- high resolution
- extracorporeal membrane oxygenation
- single molecule
- data analysis